Gianluca became Executive Vice President and President, Life Sciences, Diagnostics and Applied in April 2024. In this role, Gianluca has oversight for the Life Sciences Solutions, Specialty Diagnostics and Analytical Instruments businesses as well as our Chief Scientific Office and Quality & Regulatory Affairs function. Gianluca was appointed Executive Vice President in January 2022. He previously served as Senior Vice President and President, Specialty Diagnostics, assuming additional responsibility for our Clinical Next-Generation Sequencing business in January 2021. Gianluca joined the company through the acquisition of Life Technologies in 2014, where he was serving as President, Greater China. From 2015 through 2017, he led Thermo Fisher’s business in China, and became President, Biosciences, in 2018.

Gianluca began his career with GE Healthcare and joined Life Technologies in 2006, serving in finance leadership roles in Europe before becoming Vice President and General Manager of the Latin America business in 2010 and assuming leadership of Greater China in 2013.

Gianluca is a member of the Board of Directors of HP, Inc.  He earned a Master of Science degree in engineering from Politecnico di Torino in Italy. He served as a member of the Global Future Council on Health and Healthcare of the World Economic Forum from 2016 to 2018.